CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia (Q44379464)
Jump to navigation
Jump to search
scientific article published in May 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia |
scientific article published in May 2003 |
Statements
1 reference
CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia (English)
1 reference
Delphine Mirebeau
1 reference
Hélène Cavé
1 reference
Raphaëlle Bertin
1 reference
Cécile Acquaviva
1 reference
Christine Guidal-Giroux
1 reference
Etienne Vilmer
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference